-+ 0.00%
-+ 0.00%
-+ 0.00%

Adial Pharmaceuticals FY 2024 GAAP EPS $(2.72) Beats $(2.97) Estimate

Benzinga·03/04/2025 14:50:30
Listen to the news

Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(2.72) per share which beat the analyst consensus estimate of $(2.97) by 8.42 percent. This is a 24.44 percent increase over losses of $(3.60) per share from the same period last year.